Derby Copeland Capital funded a $54M refinance for 660 Lexington as the Midtown East condo wraps construction and begins sales. The loan replaces earlier debt as the project moves into sellout.

Atomic Wings is planning six New Jersey restaurants, with the first two set for Jersey City and Hoboken as the chain pursues major 2026 growth. The rollout will be led by a Brooklyn‑based franchisee.

A state‑funded, $32 million, 60‑bed recovery center opened on Wards Island to provide medication‑assisted treatment and stabilization for men in early recovery.

Veeva signed a 62,000‑square‑foot, 10‑year lease at Vornado’s PENN 2 and is relocating its New York office from 1375 Broadway.

Next Gen Chef winner Andrew Sargent has leased 3,133 square feet at 16 West 18th Street to open Caroline, a tasting-menu restaurant slated for spring 2027.

Andrew Amer, who led the state's civil case against Donald Trump, was named to the Court of Claims in a 28‑judge round of appointments.

Six new leases at 250 Hudson add about 119,000 sq ft and push the Hudson Square tower to roughly 99% occupancy, bringing creative, production and wellness tenants.

A Manhattan judge allowed a class-action accusing Abbott’s PediaSure of overstating its “clinically proven” growth benefits to proceed, citing packaging and ads that could imply height gains.

Insiders say Taylor Swift and Travis Kelce have save‑the‑dates for a July 3 Manhattan wedding as venues and security plans are still being finalized.

Flourish surfaced from stealth with $500M and a $2.5B valuation, backed by Bezos and top VCs, promising a low‑power 'Cortex AI' that blends neuroscience and machine learning.

eBay is moving its NYC office into a Microsoft‑anchored Flatiron landmark, signing an eight‑year lease for about 27,902 square feet. The deal fills out the renovated 122 Fifth Avenue.

A new comptroller analysis finds roughly 15,700 vacant storefronts in New York City, with the highest vacancy rates clustered in Lower Manhattan, North Brooklyn and parts of Queens.

Columbia researchers report precise base edits in early human embryos, targeting PCSK9 and HBG. Experts warn mosaicism and long‑term safety risks remain.